MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
GENEVA, Aug. 10, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today provided updates on two previously announced initiatives supporting its strategic priorities in...
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


